Sriram Sathy, Ph.D.Chief Scientific Officer at AIRNASpeaker
Profile
Sriram Sathy, Ph.D. is Chief Scientific Officer at AIRNA Biotechnology with over three decades of experience in genetic medicine, cancer biology, immunology, and neuroscience. He has advanced antibodies, exosomes, and antisense oligonucleotides from concept to clinic. Previously, as CSO of Codiak Biosciences, he led the development of first-in-class engineered exosome therapeutics (exoIL-12™, exoSTING™, exoASO™-STAT6) for cancer. He also held leadership roles at Jounce Therapeutics and Merck Research Laboratories. Sriram earned his Ph.D. from the Indian Institute of Science and completed postdoctoral research at the University of Pennsylvania. Based in Lexington, MA, he is also an avid long-distance cyclist and passionate advocate for cancer research.
Agenda Sessions
AIR-001: A Highly Potent and Precise GalNAc-conjugated RNA Base Editing Treatment for Alpha-1 Antitrypsin Deficiency
, 10:45View Session